We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Baker, SK, Silva, JE, Lam, KKS. Pseudoephedrine-inducedhemorrhage associated with a cerebral vascular malformation. Can J Neurol Sci2005;32: 248–252Google Scholar
2
2.Lo Re, V3rd, Bellini, LM. William of Occam and Occam’s razor. Ann Intern Med2002;136:634–635.Google Scholar
3
3.Qureshi, AI, Tuhrim, S, Broderick, JP, et al.Spontaneousintracerebral hemorrhage. N Engl J Med2001;344:1450–1460.Google Scholar
4
4.Yamada, M. Cerebral amyloid angiopathy: an overview. Neuropathology2000;20:8–22.Google Scholar
5
5.Kernan, WN, Viscoli, CM, Brass, LM, et al.Phenylpropanolamineand the risk of hemorrhagic stroke. N Engl J Med2000;343:1826–1832.Google Scholar
6
6.Stoessl, AJ, Young, GB, Feasby, TE. Intracerebral hemorrhage andangiographic beading following ingestion of catecholaminergics. Stroke1985;16:734–736.CrossRefGoogle ScholarPubMed
7
7.Haller, CA, Benowitz, NL. Adverse cardiovascular and centralnervous system events associated with dietary supplementscontaining ephedra alkaloids. N Engl J Med2000;343:1833–1838.Google Scholar
8
8.Health Canada. Health Canada requests a recall of certain productscontaining ephedra/ephedrine. Available at www.hc-sc.gc.caGoogle Scholar